0001171843-17-000003.txt : 20170103 0001171843-17-000003.hdr.sgml : 20170103 20170103060306 ACCESSION NUMBER: 0001171843-17-000003 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20170103 ITEM INFORMATION: Completion of Acquisition or Disposition of Assets ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20170103 DATE AS OF CHANGE: 20170103 FILER: COMPANY DATA: COMPANY CONFORMED NAME: NATUS MEDICAL INC CENTRAL INDEX KEY: 0000878526 STANDARD INDUSTRIAL CLASSIFICATION: ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS [3845] IRS NUMBER: 770154833 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 000-33001 FILM NUMBER: 17500180 BUSINESS ADDRESS: STREET 1: 6701 KOLL CENTER PARKWAY, SUITE 120 CITY: PLEASANTON STATE: CA ZIP: 94566 BUSINESS PHONE: 9252236700 MAIL ADDRESS: STREET 1: 6701 KOLL CENTER PARKWAY, SUITE 120 CITY: PLEASANTON STATE: CA ZIP: 94566 8-K 1 f8k_010317.htm FORM 8-K
 

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
_____________________

Form 8-K
_____________________

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

Date of Report (Date of earliest event Reported): January 3, 2017  

Natus Medical Incorporated
(Exact Name of Registrant as Specified in Charter)

Delaware000-3300177-0154833
(State or Other Jurisdiction of Incorporation)(Commission File Number)(I.R.S. Employer Identification Number)

 

6701 Koll Center Parkway, Suite 120, Pleasanton, CA 94566
(Address of Principal Executive Offices) (Zip Code)

925-223-6700
(Registrant's telephone number, including area code)


(Former name or former address, if changed since last report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 [   ]  Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
 [   ]  Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
 [   ]  Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
 [   ]  Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
 
 

Item 2.01. Completion of Acquisition or Disposition of Assets.

On January 3, 2017, Natus Medical Incorporated (the “Company”) completed the acquisition of the GN Otometrics ("Otometrics") from GN Store Nord A/S ("GN") that was announced on September 26, 2016. Based in Taastrup, Denmark, Otometrics provides hearing screening, hearing diagnostic and balance care tools and software to hospitals and professional worldwide.

On January 3, 2017, the Company issued a press release announcing the completion of the acquisition Otometrics. A copy of the press release is furnished as Exhibit 99.1 to this Current Report on Form 8-K.

Item 9.01. Financial Statements and Exhibits.

(a) Financial Statements of the Business Acquired.

The financial statements required by this Item, with respect to the acquisition described in Item 2.01 herein, will be filed as soon as practicable, and in any event not later than 71 days after the date on which this Current Report on Form 8-K was required to be filed pursuant to Item 2.01.

(d) Exhibits.

Exhibit No. Description
99.1 Press release dated January 3, 2017 announcing the completion of the acquisition.

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 Natus Medical Incorporated
   
  
Date: January 3, 2017By: /s/ Jonathan A. Kennedy        
  Jonathan A. Kennedy
  Executive Vice President and Chief Financial Officer
  

EXHIBIT INDEX

 

Exhibit No. Description
   
99.1 Press release dated January 3, 2017 announcing the completion of the acquisition.

EX-99.1 2 exh_991.htm PRESS RELEASE EdgarFiling

EXHIBIT 99.1

Natus Completes Acquisition of GN Otometrics Business

PLEASANTON, Calif., Jan. 03, 2017 (GLOBE NEWSWIRE) -- Natus Medical Incorporated (NASDAQ:BABY) today announced that it has completed the acquisition of GN Otometrics from GN Store Nord A/S (GN.CO) that was announced on September 26, 2016.  Based in Taastrup, Denmark, Otometrics provides hearing screening, hearing diagnostic and balance care tools and software to hospitals and professional worldwide.

About Otometrics

Otometrics is a leader in the hearing and balance assessment market.  Otometrics provides computer-based audiological, otoneurologic and vestibular instrumentation and sound rooms to hearing and balance care professionals worldwide.  Otometrics has a complete product and brand portfolio known for its sophisticated design technology in the hearing and balance assessment markets. Global brands include Aurical®, ICS® and Madsen®.

Additional information about GN Otometrics can be found at www.otometrics.com.

About Natus Medical Incorporated

Natus is a leading provider of healthcare products and services used in the screening, detection, treatment, monitoring and tracking of common medical ailments in newborn care, hearing impairment, neurological dysfunction, epilepsy, sleep disorders, and balance and mobility disorders.

Additional information about Natus Medical can be found at www.natus.com.

COMPANY CONTACT:
Natus Medical Incorporated
Jonathan A. Kennedy
Executive Vice President Finance and Chief Financial Officer
(925) 223-6700
InvestorRelations@Natus.com